Challenge study: The efficacy of fish oil supplementation on cognitive performance in MCI patients and the influence of the APOE-epsilon4 allele.

Challenge study: The efficacy of fish oil supplementation on cognitive performance in MCI patients and the influence of the APOE-epsilon4 allele. - fish oil and cognitive performance in MCI patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32051

Enrollment

Registered

2008-09-10

Start date

2008-10-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive decline

Interventions

One group (n=20) receives capsules containing an amount of 3g EPA-DHA daily and the other group (n=20) receives placebo capsules.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Men and women - Diagnosed as having amnestic MCI: based on specific memory disturbances (cut-off of 1 sd, single or multiple domain amnestic MCI) - Informed consent signed

Exclusion criteria

Exclusion criteria: - Current or recent (

Design outcomes

Primary

Measure	Time frame
Cognitive performance as assessed by sensitive cognitive tests measuring reaction time, visual memory and attention.	—

Secondary

Measure	Time frame
Cerebral blood flow will be measured by Trans-cranial Doppler.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)